The inspection has concluded successfully on 1st September 2023 without any critical/major observation
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
The approval bolsters the company's Mycophenolate Mofetil portfolio
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Subscribe To Our Newsletter & Stay Updated
